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Structured Abstract 30 
Background: Patients’ illness beliefs have been associated with glycaemic control in diabetes and 31 
survival in other conditions. 32 
Objective: We examined whether illness beliefs independently predicted survival in patients with 33 
diabetes and foot ulceration. 34 
Methods: Patients (n=169) were recruited between 2002 and 2007. Data on illness beliefs were 35 
collected at baseline. Data on survival were extracted and used to calculate number of days survived 36 
from date of recruitment to the census point (1st November 2011).  37 
Results: Logistic regressions revealed that mortality was predicted by ischemia and illness beliefs, 38 
specifically beliefs regarding symptoms (identity beliefs): patients with less ischemia and who believed 39 
their foot ulcer was associated with greater symptoms were more likely to die. Cox regressions 40 
examined the predictors of time to death and again identified ischemia and identity beliefs as significant 41 
predictors of time to death. 42 
Conclusions: These data indicate that illness beliefs have a significant independent effect on survival 43 
in patients with diabetes and foot ulceration. 44 
 45 
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The psychological functioning of patients with diabetes has been shown to be of clinical importance. 49 
For example, indices of psychological functioning have been associated with poorer metabolic 50 
control(1); greater treatment non-adherence(2) and an increased risk of diabetic complications.(3) 51 
Research with patients with diabetic foot ulcers has also been suggestive of a role for psychological 52 
factors in predicting clinical outcomes. For example, in patients with, or at risk, from foot ulceration, 53 
depression has been associated with an increased risk of ulceration,(4) delays in the rate of ulcer 54 
healing(5) and a 2 fold greater risk of mortality.(6)  55 
The evidence regarding the relationship between psychological functioning and outcomes in patients 56 
with foot ulcers has, however, largely focussed on depression and remains equivocal. For example, 57 
contrary to the studies cited above, data also exist to suggest that depression is not related to ulcer 58 
recurrence(4, 6) or amputation.(7) Similarly, the effect of depression on ulcer healing has been shown 59 
not to withstand adjustment for clinical predictors.(8) These observations lead us to speculate that a 60 
focus on depression alone may be limiting our understanding of the ways in which psychological 61 
functioning can influence clinical outcomes in diabetic foot ulceration; and that it may be necessary to 62 
examine the role of other psychological processes.(5, 9)  63 
If we are to extend our assessment of psychological factors beyond depression, which factors are worthy 64 
of further enquiry? The influential self-regulatory model of illness(10) can inform this question. The 65 
model asserts that patients form illness beliefs when contending with a health threat and that these 66 
beliefs play a central role in determining patients’ emotional and behavioural responses to their illness. 67 
In this way, illness beliefs are ‘upstream’ from emotional responses, such as depression, to illness. A 68 
recent systematic review provides evidence in support of illness beliefs being associated with glycaemic 69 
control in diabetes.(11) Furthermore, a study comparing the effects of depression versus illness beliefs 70 





beliefs were more consistent and stronger determinants of these outcomes than depression.(12)  Of 72 
particular relevance, however, is recent work with patients with other patient groups which has shown 73 
that illness beliefs predict mortality. For example, van Dijk and colleagues(13) reported in a cohort of 74 
patients with end stage renal disease that beliefs regarding treatment control predicted mortality: with 75 
death being more likely in patients who believed their treatment to be less effective. Similar findings 76 
were subsequently reported by Chilcot, Wellstead and Farrington (2011) who also found negative 77 
beliefs about the effectiveness of treatment predicted mortality in patients with end stage renal 78 
disease.(14) More recently, Crawshaw, Rimington, Weinman and Chilcot (2015) reported that changes 79 
in illness perceptions, specifically a change from positive to negative beliefs, predicted mortality in 80 
patients who had undergone cardiac vale replacement.(15) 81 
Taken together, the evidence suggests that illness beliefs may predict clinical outcomes, including 82 
mortality, in patients with diabetes including those with diabetic foot ulcers. We report on findings from 83 
a prospective cohort study in which we examined the effects of illness beliefs on mortality in patients 84 
with active ulceration. In line with previous research we hypothesised that the risk of death would be 85 
greater in patients with negative beliefs. Our predictive models were constructed to examine whether 86 
illness beliefs predicted mortality after examining the role of potential demographic and clinical 87 
determinants, as well as depression and coping. Depression was included in view of its prominence in 88 
the literature as a determinant of mortality in diabetes.(6, 7, 16) Confrontational coping was also 89 
considered a plausible determinant in light of evidence that ulcer history predicts mortality in patients 90 
with diabetic foot ulcers(16) and earlier work with this cohort has shown that confrontational coping 91 
predicts ulcer healing.(5)  92 






A convenience sample of patients with diabetes mellitus and a foot ulcer was recruited from outpatient 95 
podiatry clinics in secondary care in the UK between January 2002 and January 2007. Patients were 96 
recruited into a longitudinal research programme examining psychological and behavioural aspects of 97 
diabetic foot ulceration. This study was approved by the North Somerset & South Bristol Research 98 
Ethics Committee and all participating patients provided written informed consent.  99 
All clinics subscribed to a standard regimen of foot care, i.e., aggressive debridement at each visit, 100 
treatment of infections with antibiotics and the use of removable Scotch-casts and other 101 
footwear/devices for offloading ulcers on weight-bearing areas, minimising the likelihood of between-102 
centre variations in treatment outcomes. Inclusion/exclusion criteria ensured the population consisted 103 
of patients with neuropathic or neuroischaemic ulcers. Patients were not eligible if they had: no palpable 104 
pulses on the affected foot; a history of major amputation (i.e., any lower limb amputation greater than 105 
a single digit); known large vessel peripheral vascular disease (e.g., previous bypass surgery, 106 
angioplasty); advanced diabetic retinopathy with severe visual impairment; advanced nephropathy (e.g., 107 
on dialysis); other severe disabling medical conditions (e.g., stroke); or were being treated with platelet-108 
derived growth factor, tissue engineered skin or total contact casts.  109 
One hundred and sixty-nine patients were recruited. In November 2011, survival data (i.e., deceased 110 
versus alive at 1/11/11; and, if deceased, date of death) were requested from General Practitioners. Data 111 
were available for 160 patients (n=104 alive at census point; n=32 deceased and date of death known; 112 
n=24 deceased and date of death not known). No data were available for 9 patients. These patients were 113 
excluded from the analyses. Analyses were conducted to compare patients with and without survival 114 
data on all the predictor variables. No differences were evident between the groups on any variable (data 115 
not shown), with the exception of age which approached significance (p=0.056): patients with missing 116 






Illness beliefs: Participants completed the Brief Illness Perceptions Questionnaire (BIPQ)(17) derived 119 
from the self-regulatory model of illness.(10) This instrument is recommended in studies involving 120 
older participants and/or ill participants and so was selected for the present study. The instrument 121 
captured patients’ beliefs regarding their foot ulcer in the following domains: identity (‘How much do 122 
you experience symptoms?’); consequences (‘How much does your ulcer affect your life?’); timeline (How 123 
long do you think your ulcer will continue?); personal control (‘How much control do you feel you have over 124 
your ulcer?’); treatment control (‘How much do you think your treatment can help your ulcer?’); coherence 125 
(‘How well do you feel you understand your ulcer?’) and emotional response (‘How much does your ulcer 126 
affect you emotionally?’). The range of scores for each subscale was 0-10, with higher scores indicating 127 
a stronger belief in the relevant domain. The reliability, concurrent and predictive validity of the 128 
instrument has been reported elsewhere.(17, 18)  129 
Depression: Depression was measured using the depression subscale of the Hospital Anxiety and 130 
Depression Scale (HADS).(19) The range of scores for this subscale was 0-21, with higher scores 131 
reflecting higher levels of depression. The Cronbach’s alpha reliability coefficient for the subscale in 132 
the present study was 0.849. 133 
Confrontational coping:  Confrontation coping was measured using the confrontation subscale of the 134 
Medical Coping Modes Questionnaire.(20) Range of scores for this subscale was 1-26, with higher 135 
scores indicating a greater propensity towards confrontational coping. Confrontational styles are 136 
characterised as being more controlling, competitive and extroverted. The Cronbach’s alpha reliability 137 
coefficient for the subscale in the present study was 0.709. 138 
Glucose control: Glycated haemoglobin (HbA1c) was measured to provide a surrogate marker of 139 
disease control 2-3 months prior to study entry. HbA1c was measured by cation exchange high 140 
performance liquid chromatography using a Menarini HA-8140 analyser and associated reagents (A. 141 





Control and Complications Trial method,(21) with no significant assay drift and a between-batch 143 
imprecision (CV) of 1.8% (at mean HbA1c 5.5% [37 mmol/mol]). All assays were performed on the 144 
same instrument. 145 
Neuropathy and ischaemia assessments: Neuropathy was assessed by applying a 10g nylon 146 
monofilament to a number of sites on the affected foot and patients reporting the presence/absence of 147 
sensation. Level of neuropathy was based upon the number of tested sites with sensory loss. Percentage 148 
rather than absolute values were used as the number of sites assessed varied between podiatrists. 149 
Ischaemia was assessed by measuring number of palpable pulses at the dorsalis pedis and posterior 150 
tibial areas of the affected foot. All assessments were conducted by the treating podiatrist at each centre. 151 
Ulcer assessments: Data were collected from clinical records on all patients regarding the number of 152 
previous ulcers the size of the presenting ulcer and the presence/absence of infection in the presenting 153 
ulcer. The assessment of ulcer size involved placing a disposable transparent film over the ulcer and 154 
tracing the topical area of the ulcer. The tracing was then placed on a digital tablet (Visitrack: Smith 155 
and Nephew, London, UK) and the area of the ulcer was re-traced with a stylus to produce a 156 
measurement of absolute ulcer area (in mm2). These assessments were conducted by the treating 157 
podiatrist at each centre. 158 
Statistical methods 159 
One way analysis of variance and chi-square analysis were conducted to compare patients with and 160 
without missing survival data on all predictor variables. After checking that assumptions were satisfied, 161 
survival analysis was undertaken using both logistic regression (to examine the predictors of whether 162 
or not patients died over the observation period) and Cox regression models (to examine the predictors 163 
of time to death). For the latter the survival outcome was number of days survived from the date of 164 
recruitment to the census point (1/11/11) or death from any cause. Both survival analyses involved two 165 





coping were examined in univariate analyses to identify significant predictors. In the second step, all 167 
seven belief measures were added to only those covariates identified as being significant in the first 168 
step. Although this resulted in our models having up to ten predictors, this approach is in keeping with 169 
contexts in which it is appropriate to relax the rule of ten predictors per number of outcomes(22); and 170 
the self-regulatory model(10) which argues that a patients’ understanding of their illness, and 171 
subsequent behavioural and emotional responses, are influenced by all of the belief domains represented 172 
in the model. 173 
As both the predictor and outcome variables contained missing values, imputation methods were used 174 
to maximise the available data for the survival analysis. The independent variables appeared to be 175 
missing completely at random: Little’s test(23) returned a p-value of 0.74. As only 79 out of the 160 176 
patients contained no missing values, we imputed the missing predictor values using k-nearest 177 
neighbours, with k=5, to ensure there was sufficient power.(24) For the outcome measures, survival 178 
status was known for 160 patients. Of these, 24 were known to have died, but their date of death was 179 
unknown. Thus, we performed multiple imputations to estimate the survival time for these patients. Five 180 
imputation techniques were used, the first considered the patients to survive midway between their 181 
inclusion into the study and study end date. The second identified the average proportion of time 182 
between patients’ start dates and the study end date for all the patients who died with a known date of 183 
death and estimated the patient’s death to be the same ratio between their start date and the study end 184 
date. The third imputed survival time was based on the survival time of the patient with the closest start 185 
date and the fourth survival time was based on the survival time of the four patients with the closest 186 
start date.  The fifth survival time was based on the average of the previous four survival times. 187 
Using these datasets we then performed the logistic regression and Cox survival analysis. As the logistic 188 
regression does not rely on survival time, we performed the logistic regression without survival 189 





Missing imputation methods were implemented using R, a free software environment for computing 191 
and graphics.(25) All other analyses used SPSS, Version 19. 192 
Procedure 193 
Patients participated in a prospective observational study. At baseline, the following clinical and 194 
demographic data were collected on all participants: age, gender, glycosylated haemoglobin (HbA1c), 195 
number of previous ulcers, presence/absence of infection in ulcer, diabetes type, neuropathy and 196 
ischemia and ulcer size. Participants also completed self-report measures of illness beliefs,(17) 197 
depression(19) and confrontation coping(20) at baseline. Data on survival were collected after the 198 
survival census point (1st November 2011). 199 
RESULTS 200 
Cohort Characteristics 201 
Table 1 shows that the average period patients survived in this study was 6 years (range 57-3534 days); 202 
the average age of participants was 60 years and, in keeping with the known prevalence of these ulcers, 203 
two-thirds of our participants were male. The clinical data indicated moderately high levels of 204 
neuropathy and ischemia and average HbA1c levels suggested poor glucose control. Most patients had 205 
had an ulcer previously and for approximately one-third of patients the index ulcer was infected at study 206 
entry. The psychological data revealed, on average, low levels of depression and modest levels of 207 
confrontation coping. The illness beliefs measure indicated that patients reported that they experienced 208 
few physical symptoms associated with their ulcers (identity beliefs); believed their ulcers had 209 
significant consequences for them (consequence beliefs); and were likely to last a moderately long time 210 
(timeline beliefs). Patients also reported moderate levels of personal control over their ulcers (personal 211 





Coherence beliefs suggested that patients’ perceived they had a moderately good understanding of their 213 
ulcers and also believed that their ulcers affected their emotional well-being. 214 
Table 1: Clinical, demographic and psychological characteristics of the cohort 215 
 Mean (standard deviation) / Frequency Available data (N) 
Survival (days) 2233 (+/-912) 136 
Gender 100 male / 36 female 136 
Age 60.25 (+/-11.89) 136 
HbA1c % [mmol/mol] 8.70 (+/-1.82); [72 +/-19.9] 129 
Number of previous ulcers 1 (+/-3) 120 
Ulcer infected at baseline 50 yes / 85 no 135 
Diabetes type 1/2 Type 1=39/Type 2=94 133 
Ulcer area at baseline (mm2) 18.02 (34.68) 125 
Neuropathy score (%) 72 (+/-33) 130 
Ischemia score (%) 73 (+/-34) 131 
Depression 5.78 (+/-4.28) 111 
Confrontation coping 17.95 (+/-3.7) 109 
Identity beliefs 2.99 (+/-2.86) 102 
Consequence beliefs 6.53 (+/-2.07) 100 
Timeline beliefs 5.97 (+/-1.85) 102 
Personal control beliefs 6.03 (+/-2.46) 99 
Treatment control beliefs 8.17 (+/-1.36) 101 
Coherence beliefs 6.05 (+/-2.15) 102 
Emotional response beliefs 5.61 (+/-2.66) 102 
 216 
Examining predictors of mortality 217 
The results from univariate logistic regression analyses examining the role of potential clinical and 218 
demographic predictors, and depression and coping, on mortality revealed that age (OR 1.035, 219 
p=0.022), diabetes type (1/2) (OR .419, p=0.033) and ischemia (OR .975, p <0.0001) were significant 220 





depression nor coping emerged as significant predictors. In the multivariate model, the inclusion of the 222 
illness belief measures revealed that, although ischemia and diabetes type (1/2) continued to be 223 
significant predictors of mortality, age was no longer significant. In addition, coherence beliefs emerged 224 
as a significant predictor of mortality (OR .765, p=0.027); and identity beliefs approached significance 225 
(OR 1.215, p=0.092). The direction of these associations suggested that patients were more likely to die 226 
if they had less ischemia; type 1 diabetes; a poorer understanding of their condition and perceived they 227 
had more symptoms. These analyses were repeated following imputation of missing data for the 228 
predictor variables, as described above, and the results remained largely unchanged. Specifically, age, 229 
diabetes type and ischemia emerged as the only significant predictors in the univariate analysis. The 230 
inclusion of illness beliefs in the multivariate model identified only ischemia (OR 0.347 p <0.0001) and 231 
identity beliefs (OR 1.871, p=0.054) as significant predictors of mortality. The effects of age and 232 
coherence beliefs were reduced to non-significant: p=0.102 and p=0.197 respectively (all other data not 233 
shown). 234 





Table 2: Results from logistic regression examining effects of all clinical and demographic covariates and depression and coping 236 
(univariate analyses); and only significant covariates from step 1 with illness beliefs (multivariate analysis) on mortality status 237 
Univariate analyses    Multivariate analysis    
Covariate Odds 
ratios 
p 95%CI Covariate Odds 
ratios 
p 95%CI 
Age 1.035 .022 1.005-1.066 Age 1.003 .898 .960-1.048 
Gender 1.351 .445 .625-2.922 Diabetes 1/2 0.288 .053 .081-1.018 
Ulcer area at baseline 
(mm2) 
1.001 .893 .990-1.011 Ischemia 0.973 .000 .960-.987 
Ulcer infected at baseline .666 .231 .343-1.295 Consequence beliefs 0.866 .374 .6311-.189 
Diabetes 1/2 .419 .033 .189-.931 Timeline beliefs 1.053 .722 .792-1.4 
Number of previous ulcers 1.048 .523 .908-1.21 Personal control beliefs 1.137 .233 .921-1.404 
HbA1c .928 .429 .772-1.116 Treatment control 
beliefs 
0.864 .456 .589-1.268 
Depression .946 .232 .864-1.036 Identity beliefs 1.215 .092 .969-1.523 
Confrontation coping 1.014 .785 .919-1.118 Coherence beliefs 0.765 .027 .603-.970 
Neuropathy 1.011 .072 .999-1.023 Emotional response 
beliefs 
0.879 .234 .710-1.087 






Examining predictors of time to death 239 
As with the previous analysis, the first step involved univariate Cox regression models in which we 240 
examined the role of potential clinical and demographic predictors and depression and coping. The 241 
results revealed that only diabetes type (1/2) and ischemia were significant predictors of time to death 242 
(see Table 3). In the multivariate model, the measures of illness beliefs were added to these significant 243 
covariates. These results showed that ischemia remained a significant predictor of time to death (HR 244 
0.976, p<0.0001) and that, as with the logistic regression analyses, coherence (HR 0.775, p=0.036) and 245 
identity beliefs (HR 1.245, p=0.036) also emerged as significant predictors, with treatment control 246 
beliefs (HR 0.735), p= 0.086) approaching significance. Specifically, patients with less ischemia; a 247 
poorer understanding of their condition; who perceived they had more symptoms; but also a greater 248 





Table 3: Results from Cox regression analyses examining effects of all clinical and demographic covariates and depression and coping 250 
(univariate analyses); and only significant covariates from step 1 with illness beliefs (multivariate analysis) on time to death 251 
Univariate analyses    Multivariate analysis    
Covariate Hazard 
ratios 
p 95%CI Covariate Hazard 
ratios 
p 95%CI 
Age 1.021 .179 .990-1.053 Diabetes 1/2 .395 .107 .128-1.223 
Gender 1.029 .945 .462-2.291 Ischemia score .976 .000 .965-.987 
Ulcer area at baseline 
(mm2) 
1.003 .585 .993-1.012 Consequence beliefs .959 .817 .671-1.370 
Ulcer infected at baseline .792 .512 .394-1.592 Timeline beliefs .993 .965 .717-1.374 
Diabetes 1/2 .304 .026 .107-.868 Personal control beliefs 1.085 .465 .872-1.351 
Number of previous 
ulcers 
1.086 .182 .962-1.227 Treatment control beliefs .735 .086 .517-1.045 
HbA1c .869 .181 .708-1.067 Identity beliefs 1.245 .036 1.014-1.529 
Depression .975 .579 .892-1.066 Coherence beliefs .775 .036 .610-.983 
Confrontation coping 1.014 .782 .918-1.120 Emotional response 
beliefs 
.890 .274 .722-1.097 
Neuropathy 1.005 .381 .994-1.017     






These analyses were repeated following imputation of missing predictor and outcome data as described 253 
above, and the results remained largely unchanged. In particular, regardless of which of the 5 imputation 254 
methods were used on the time to death variable, the univariate analyses revealed that only the measures 255 
of ischemia, diabetes type (1/2) and age were significant independent predictors of time to death (data 256 
not shown). Similarly, the multivariate analyses which included the illness belief measures revealed that 257 






Table 4: Cox regression analyses using imputed data to examine effects of significant clinical and demographic and illness beliefs on 260 



























































































































































We examined the role of illness beliefs in predicting mortality and time to death in patients with diabetic 264 
foot ulcers; controlling for other potential clinical and demographic determinants, as well as depression 265 
and confrontational coping. These analyses were conducted with and without imputation of missing 266 
data. The results from the multivariate models, without imputation, revealed that ischemia, coherence 267 
and identity beliefs predicted both mortality and time to death. Specifically, death was more common 268 
and occurred more quickly in individuals with less ischemia, who perceived their ulcers were associated 269 
with greater symptoms and had a poorer understanding of their condition. When these analyses were 270 
repeated with imputation of missing data for the predictor variables (logistic regressions) and imputation 271 
of missing data for both the predictor and outcome variables (Cox regressions), the findings were largely 272 
unchanged, with ischemia and identity beliefs emerging as significant predictors of both mortality and 273 
time to death in all analyses. In view of the increased power associated with the imputed datasets, the 274 
discussion of our findings will focus, primarily, on these results. 275 
Our findings have several implications. First, they add to an existing literature which has shown that 276 
patients’ illness beliefs can influence clinical outcomes in diabetes (e.g., quality of life, glycaemic 277 
control(11, 12)). In the present work, both survival analyses identified an independent role for illness 278 
beliefs in predicting survival. These results are also in keeping with findings from other patient 279 
groups(14, 15) and a recent systematic review(26) all of which have shown how negative beliefs 280 
regarding one’s illness is predictive of mortality over periods as short as 1.32 years(14) and as long as 281 
10 years.(26) 282 
Second, these results suggest that approaches to understanding mortality risk in this patient group(27) 283 
may be improved through the inclusion of illness beliefs in risk models. Our data showed that, even 284 
after controlling for other predictors, illness beliefs predicted survival; and that identity beliefs emerged 285 





modifiable, but that illness belief based interventions can produce significant changes in a range of 287 
outcomes (e.g., adherence behaviours, mood, return to work) and across many different diseases, 288 
including diabetes (28-31); suggests that the measurement of illness beliefs may not only improve our 289 
understanding of the risk factors associated with mortality, but could also be incorporated into 290 
interventions to improve survival. Although detailed consideration of the features and mechanisms of 291 
such an intervention is beyond the scope of this paper, it could be hypothesised that evidence identifying 292 
significant prospective relationships between illness beliefs and glycaemic control(11)  and illness 293 
beliefs and self-care behaviours(32) suggests that any such intervention could improve survival via these 294 
pathways. 295 
A related issue concerns the mechanisms underlying the seemingly central role of identity beliefs in 296 
predicting mortality. Identity beliefs are concerned with an individual’s perception of the extent to 297 
which their condition is symptomatic and are often associated with more favourable outcomes (e.g., 298 
better adherence, attendance at cardiac rehabilitation, etc.(33, 34) However, in the present study, the 299 
experience of greater symptoms was associated with an increased risk of death. This finding could 300 
simply reflect the fact patients with greater symptoms had a greater burden of illness which resulted in 301 
the greater risk of mortality. Alternatively, the seemingly counter-intuitive role of identity beliefs in this 302 
patient group may be related to the unique nature of their condition. Specifically, our 303 
inclusion/exclusion criteria were intended to enable us to recruit patients with ulcers which were 304 
primarily neuropathic or neuroischemic. One of the defining features of such ulcers is that they are 305 
largely pain-free due to the nerve damage associated with neuropathy. Thus, we hypothesise, that 306 
patients with a largely painless condition who have high identity beliefs may have poorer outcomes 307 
because they erroneously associate pain and related symptoms with severity. Thus, an absence of pain 308 
may lead them to underestimate the seriousness of their ulcers; make them less likely to access 309 






A further issue relates to our finding that ischemia was associated with a survival advantage. As with 312 
identity beliefs, ischemia was found to predict both mortality and time to death in all analyses, thereby 313 
suggesting that, although counterintuitive, it was a robust finding. However, a number of issues should 314 
be considered when interpreting this result. First, our approach to measuring ischemia involved a single 315 
assessment (i.e., the measurement of the number of palpable pulses). However, the accurate 316 
measurement of ischemia requires multiple, not single, methods.(35) Thus, our approach, while 317 
pragmatic (we selected one method which could be conducted rapidly across all clinics), lacked 318 
precision and this may have contributed to our finding. Second, as stated, our inclusion criteria were 319 
intended to enable us to recruit patients with neuropathic or neuroischaemic ulcers i.e., patients with no 320 
palpable pulses (severe ischemia) were excluded. As a result, the patients in this cohort with the greatest 321 
levels of ischemia, were likely to be individuals with only moderate ischemic disease; and patients with 322 
low levels of ischemia likely to be patients experiencing greater neuropathy. As the treatments for 323 
microvascular complications such as neuropathy are considered not to be as effective as treatments for 324 
macrovascular complications,(36) this might explain the apparent survival advantage in our patients 325 
with moderate ischemia. In other words, moderate ischemia in this study may have been a marker of 326 
less severe neuropathy thus contributing to the observed relationship with mortality and time to death. 327 
The final issue relates to the observation that depression did not influence survival. This finding is 328 
consistent with research showing that the effects of depression on clinical outcomes in diabetes are 329 
equivocal.(27) Indeed, our data support a growing literature suggesting that a focus on depression in 330 
isolation may not be helpful when considering how psychological factors, and psychological 331 
interventions, influence clinical outcomes in diabetes.(12, 37, 38) In the case of the present work, we 332 
were unable to detect a statistically significant independent effect of depression. However, it is worth 333 
noting that post-hoc analyses (data not shown) revealed that depression was significantly positively 334 
correlated with identity beliefs, thus suggesting the potential for an indirect effect of depression on 335 





In summary, our analyses have shown a significant independent effect of patients’ illness beliefs on 337 
survival in patients with diabetic foot ulcers. Potential limitations of this work relate to the modest 338 
sample size and the exclusion of patients for whom we were unable to obtain survival data from clinical 339 
records. However, it is worth noting that our sample size was greater than the mean sample size reported 340 
in a systematic review of previous work examining the role of illness beliefs in survival(26); and our 341 
excluded patients did not differ from the rest of the cohort on any of the predictors of survival. Finally, 342 
our approach to measuring illness beliefs was pragmatic but lacked precision. Although the brief IPQ 343 
is particularly suitable for studies with older and/or frail patients, it relies on single items for the 344 
measurement of each belief domain and this necessarily precludes a detailed analysis of patients’ beliefs. 345 
Notwithstanding these limitations, these results broaden our understanding of the role of psychological 346 
processes in diabetes and add to the growing literature suggesting that individuals’ beliefs about their 347 
illness may have prognostic significance. 348 
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